Occupational Activity – Page 24

James Sabry Departs Roche After 14 Years, Returns to Biotech Industry

11 months ago talkbio0Tagged biotech, career, Drug Industry, genentech, James, Partnering, Roche (company), Sabry

James Sabry, Roche, Genentech, Biotech, Partnering, Pharmaceutical Industry, Career Moves

Revolutionizing CAR-Ts: The Future of Automation and Decentralization in Cell and Gene Therapy Manufacturing

11 months ago11 months ago talkbio0Tagged Advanced therapies, Automation, CAR-Ts, Cells, Decentralization, Digital X-ray, gene therapy, Manufacture, Patient-Centered Care, Precision Medicine, Preventive monitoring, quality management systems, real-time, Regulatory Compliance, Supply chain logistics

Automation, Decentralization, CAR-Ts, Cell and gene therapy manufacturing, Advanced therapies, Personalized medicine, Regulatory compliance, Quality management systems, Supply chain logistics, Digital solutions, Real-time monitoring, Patient-centered care

Eli Lilly Invests $5.3 Billion to Boost Production of Mounjaro and Zepbound

11 months ago11 months ago talkbio0Tagged Diabetes, Drug Industry, eli lilly, Investments, Manufacture, Mounjaro, Obesity, Weight Loss, Zepbound

** Eli Lilly, Mounjaro, Zepbound, Manufacturing, Investment, Diabetes, Obesity, Weight Loss, Pharmaceutical Industry

Cytokinetics’ Royalty Agreement Dampens Merger and Acquisition Hopes, Say Investors

11 months ago talkbio0Tagged Acquisition (action), biotech, Cytokinetics, Industry, investors, Merger, merger and acquisition, Royalty

Cytokinetics, Merger and Acquisition (M&A), Royalty Agreement, Investors, Biotech Industry

Biopharma Downsizing Trends 2024: Major Companies Adjusting Workforce

11 months ago talkbio0Tagged Biopharma, Industry, Takeda, trends qualifier

Biopharma, layoffs, downsizing, workforce reduction, Evotec, Lyra Therapeutics, Takeda Pharmaceuticals, industry trends, 2024

BIO Undergoes Transformative Restructuring for Future Growth

11 months ago talkbio0Tagged Bio, Biotechnology, cell transformation, Growth, Industry, lobbying group, reorganization, restructuring

BIO, lobbying group, reorganization, restructuring, layoffs, future growth, transformation, biotechnology industry.

AstraZeneca Invests $1.5 Billion in Singapore for Comprehensive Antibody-Drug Conjugate Manufacturing

11 months ago talkbio0Tagged Antibody-Drug Conjugates, AstraZeneca, Biotechnology, Cancer Therapeutic Procedure, end-to-end, Investments, Manufacture, production, Singapore

AstraZeneca, Singapore, antibody-drug conjugate (ADC), manufacturing, investment, biotechnology, pharmaceuticals, end-to-end production, cancer treatment.